Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda
Open Access
- 3 June 2009
- journal article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 9 (1) , 81
- https://doi.org/10.1186/1471-2334-9-81
Abstract
Little is known about immunovirological treatment outcomes and adherence in HIV/AIDS patients on antiretroviral therapy (ART) treated using a simplified management approach in rural areas of developing countries, or about the main factors influencing those outcomes in clinical practice.Keywords
This publication has 40 references indexed in Scilit:
- Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosisJournal of Antimicrobial Chemotherapy, 2007
- Positive outcomes of HAART at 24 months in HIV-infected patients in CambodiaAIDS, 2007
- Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South AfricaPublished by Elsevier ,2006
- Rapid Scale-up of Antiretroviral Therapy at Primary Care Sites in ZambiaJAMA, 2006
- Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in AfricaAIDS, 2006
- Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in MalawiPublished by WHO Press ,2006
- Response to Antiretroviral Therapy in HIV-Infected Patients Attending a Public, Urban Clinic in Kampala, UgandaClinical Infectious Diseases, 2006
- Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited SettingJournal of Clinical Microbiology, 2005
- Evaluation of antiretroviral therapy results in a resource‐poor setting in Blantyre, MalawiTropical Medicine & International Health, 2005
- Therapeutic Responses to AZT + 3TC + EFV in Advanced Antiretroviral Naive HIV Type 1-Infected Ugandan PatientsAIDS Research and Human Retroviruses, 2002